So report the Financial Times, saying the drug regulator in the country is . (FT may be gated.)
The UK’s Medicines and Healthcare Products Regulatory Agency has the power to temporarily authorise products, in cases of urgent public need, thus bypassing the normal approval required from the European Medicines Agency (what this means is that while the
